IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL - ANVISA Registration 80000230091
Access comprehensive regulatory information for IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80000230091 and manufactured by AGILENT TECHNOLOGIES, INC.. The registration is held by AGILENT TECHNOLOGIES BRASIL LTDA with validity until Oct 21, 2034.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including VENTANA MEDICAL SYSTEM, INC, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamRelated Devices (2)
Registration Details
80000230091
25351338285202485
03290250000100
Company Information
Dates and Status
Oct 21, 2024
21/10/2034
09/18/2025 19:00:01
IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL
FAMÍLIA DE MARCADORES DE CARCINOMAS EM GERAL
Not specified
80358430001
Mar 31, 2010
IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL
FAMÍLIA DE MARCADORES DE CARCINOMAS EM GERAL
CELL MARQUE CORPORATION
80358430001
Mar 31, 2010
IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL
Familia de Cancer Geral
VENTANA MEDICAL SYSTEM, INC
10287410788
May 18, 2009
IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL
Familia de Cancer Geral
Not specified
10287410788
May 18, 2009
IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL
FAMÍLIA ANTICORPOS PARA DETECÇÃO DE CARCINOMAS EM GERAL
Not specified
10337990035
Jul 02, 2018
VENTANA MEDICAL SYSTEM, INC• United States of America
ROCHE DIAGNOSTICS GMBH• Germany
AGILENT TECHNOLOGIES, INC.• United States of America
AGILENT TECHNOLOGIES SINGAPORE (INTERNATIONAL) PTE LTD.• Singapore
CELL MARQUE CORPORATION• United States of America
IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS EM GERAL
INSM1 (SP493) Rabbit Monoclonal Primary Antibody
VENTANA MEDICAL SYSTEM, INC
10287411763
Sep 15, 2025
IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS EM GERAL
INSM1 (SP493) Rabbit Monoclonal Primary Antibody
Not specified
10287411763
Sep 15, 2025
IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS EM GERAL
CD68 (SP251v18) Rabbit Monoclonal Antibody
VENTANA MEDICAL SYSTEM, INC
10287411757
Sep 01, 2025
IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS EM GERAL
CD68 (SP251v18) Rabbit Monoclonal Antibody
Not specified
10287411757
Sep 01, 2025
IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS EM GERAL
Familia Câncer Geral VENTANA
VENTANA MEDICAL SYSTEM, INC
10287411701
Aug 19, 2024